ARCHIVES

Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS

This article is from The Cancer Letter archive.

Vol. 17 No. 37 | September 27, 1991

Download PDF Visit The Full Archive

Related Articles

In Brief: Kripke, Fidler To Leave FCRF for M.D. Anderson; George Todaro Takes Job With New Seattle Firm

March 4, 1983

New Research Ideas In Immodiagnosis Suggested For RFPs

October 21, 1977

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

March 12, 1976

NCI CTEP: Approved Trials For The Month of October

October 28, 2011

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

Joe Gray Moves To OHSU Knight Cancer Institute

January 21, 2011